Read + Share
Tokumaru S, Koizumi T, Sekino Y, Takeuchi N, et al. Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment
with Nivolumab for Gastric Cancer. Oncology 2021 Jul 19:1-9. doi: 10.1159/000517344.
PMID: 34280933
|
 |
|
Tokumaru S, Koizumi T, Sekino Y, Takeuchi N, et al. Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment
with Nivolumab for Gastric Cancer. Oncology 2021 Jul 19:1-9. doi: 10.1159/000517344.
PMID: 34280933
|
|
|
|